{"date": "2021-12-03 21:47:43.415000+00:00", "ticker": "AMZN", "mrkt_info": {"open": 3437.36, "close": 3427.37}, "html": "<div class=\"storyContent\" lang=\"en\"><style type=\"text/css\">.storyContent * {border-color:inherit !important;outline-color:inherit !important;}</style><div class=\"storyframe\" id=\"storydiv\"><div class=\"TEXT\" id=\"storybody\" name=\"storybody\"><div id=\"storybodycontent0\"><span class=\"storycontent\"><pre>Click the following link to watch video: <a href=\"https://share.newscasts.refinitiv.com/link?entryId=1_qr0pjqny&amp;referenceId=1_qr0pjqny&amp;pageId=RefinitivNewscasts\" data-type=\"url video-url\" translate=\"no\">https://share.newscasts.refinitiv.com/link?entryId=1_qr0pjqny&amp;referenceId=1_qr0pjqny&amp;pageId=RefinitivNewscasts</a></pre>Source: Stocktube<br/><br/>Description: The Hydration Pharmaceuticals Company Ltd CEO Oliver Baker tells Proactive the health and wellness group, which manufactures its Hydralyte branded glucose and electrolyte supplements will begin trading on the ASX on December 13th.&amp;#xD;&amp;#xD;Baker says the group has their eye on North America, where it will develop its e-commerce business led by Amazon in the US, as well as its omni-channel strategy in Canada including through pharmacies and online.<br/>Short Link: <a href=\"https://refini.tv/3IisWO8\" data-type=\"url\" class=\"tr-link\" translate=\"no\">https://refini.tv/3IisWO8</a><br/><br/>Video Transcript:<br/><br/>Verified transcript not available</span></div></div></div></div>"}